COPLAND ROAD CAPITAL NEW
Research COPLAND ROAD CAPITAL NEW (A2P) on Bullrun: market cap EUR 699.39M, P/E 16.9, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerA2P
- ExchangeF
- CountryPoland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 699.39M
- P/E16.9
- Dividend yield3.2%
- Financial periodQ1 2026
- RevenuePLN 213.19M
- Net incomePLN 296.36M
- Free cash flow-PLN 32.79M
- Gross margin36.7%
Valuation Snapshot
latest market cap is EUR 699.39M; P/E is 16.9; dividend yield is 3.2%.
Peer valuation comparison
Latest P/E is 16.94x versus a Healthcare sector median of 24.46x (30.7% below).
Latest dividend yield is 3.23% versus a Healthcare sector median of 2.11% (53.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | PLN 706.15M | PLN 111.64M | PLN 49.66M | 36.5% | n/a | PLN 166.24M | PLN 32.37M | PLN 258.34M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 699.39M | 16.9 | 3.1% | 2.55 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.55 EUR, yield 3.2%.
About COPLAND ROAD CAPITAL NEW
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is COPLAND ROAD CAPITAL NEW's market cap?
COPLAND ROAD CAPITAL NEW's market capitalization is EUR 699.39M.
What is COPLAND ROAD CAPITAL NEW's P/E ratio?
COPLAND ROAD CAPITAL NEW's price-to-earnings (P/E) ratio is 16.9.
Does COPLAND ROAD CAPITAL NEW pay a dividend?
COPLAND ROAD CAPITAL NEW has a dividend yield of 3.2%.
What does COPLAND ROAD CAPITAL NEW do?
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.